Glycaemic control and hypoglycaemia benefits with insulin glargine 300 U/mL extend to people with type 2 diabetes and mild‐to‐moderate renal impairment

AIM: To investigate the impact of renal function on the safety and efficacy of insulin glargine 300 U/mL (Gla‐300) and insulin glargine 100 U/mL (Gla‐100). MATERIALS AND METHODS: A meta‐analysis was performed using pooled 6‐month data from the EDITION 1, 2 and 3 trials (N = 2496). Eligible participa...

Descripción completa

Detalles Bibliográficos
Autores principales: Javier Escalada, F., Halimi, Serge, Senior, Peter A., Bonnemaire, Mireille, Cali, Anna M. G., Melas‐Melt, Lydie, Karalliedde, Janaka, Ritzel, Robert A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282564/
https://www.ncbi.nlm.nih.gov/pubmed/30003642
http://dx.doi.org/10.1111/dom.13470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282564/
https://www.ncbi.nlm.nih.gov/pubmed/30003642
http://dx.doi.org/10.1111/dom.13470

Ejemplares similares